| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Belite Bio, Inc (BLTE) has 1 insider with recent SEC Form 4 filings, including 0 buys and 21 sells. BLTE is classified in the Biotechnology industry within the Healthcare sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 766 | $109.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | Mata Nathan L. | Chief Scientific Officer | Sell | 1,000 | $153.84 | $153,838.71 | -13.7% | - | - | |
| May 1, 2026 | Mata Nathan L. | Chief Scientific Officer | Sell | 1,000 | $155.78 | $155,777.84 | -3.1% | - | - | |
| Apr 20, 2026 | Mata Nathan L. | Chief Scientific Officer | Sell | 1,000 | $163.59 | $163,594.55 | -1.1% | - | - |